Cross-institution positioning
Aug 6, 2026Strong institutional reduction. 2 reducing, 1 exited across 3 comparable institutions.
Source: Schedule 13 researchCROWN HOLDINGS, INC.
Latest stored close $108.88 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 2 reducing, 1 exited across 3 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 2 sales by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Director or executive change. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +16.5% YoY; Net income +35.4% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 69% through its reported 52-week range; +17.6% over one year.
Source: Stored historical price seriesFiled Aug 6, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Rost John M | FTax/price withholding or payment | Common | 146 | $119.87 | Direct | Aug 4, 2026 |
| Aug 3, 2026 | NOVAES DJALMA JR | FTax/price withholding or payment | Common | 104 | $119.87 | Direct | Aug 4, 2026 |
| Aug 3, 2026 | Gavin Gary M | FTax/price withholding or payment | Common | 61 | $119.87 | Direct | Aug 4, 2026 |
| Jul 29, 2026 | Wilson Dwayne Andree | AGrant, award, or other acquisition · derivative | Deferred Stock | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | WILLIAMS MARSHA C | AGrant, award, or other acquisition | Common | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | Sweitzer Caesar F | AGrant, award, or other acquisition | Common | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | Snyder Angela M | AGrant, award, or other acquisition | Common | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | HAGGE STEPHEN J | AGrant, award, or other acquisition | Common | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | Owens B Craig | AGrant, award, or other acquisition | Common | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | Funk Andrea J. | AGrant, award, or other acquisition | Common | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | FEARON RICHARD H | AGrant, award, or other acquisition | Common | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 29, 2026 | DOSS MICHAEL P | AGrant, award, or other acquisition · derivative | Deferred Stock | 351 | $117.69 | Direct | Jul 30, 2026 |
| Jul 15, 2026 | DONAHUE TIMOTHY J | SOpen-market or private sale | Common | 7.5K | $110.29 | Direct | Jul 15, 2026 |
| Jun 23, 2026 | DONAHUE TIMOTHY J | SOpen-market or private sale | Common | 15.0K | $105.00 | Direct | Jun 23, 2026 |
| May 15, 2026 | Rost John M | FTax/price withholding or payment | Common | 785 | $96.08 | Direct | May 18, 2026 |
| May 15, 2026 | Gavin Gary M | FTax/price withholding or payment | Common | 3.1K | $96.08 | Direct | May 18, 2026 |
| May 15, 2026 | Madeksza Matt | FTax/price withholding or payment | Common | 984 | $96.08 | Direct | May 18, 2026 |
| May 6, 2026 | DOSS MICHAEL P | AGrant, award, or other acquisition · derivative | Deferred Stock | 417 | $99.04 | Direct | May 7, 2026 |
| May 6, 2026 | FEARON RICHARD H | AGrant, award, or other acquisition | Common | 417 | $99.04 | Direct | May 7, 2026 |
| May 6, 2026 | Funk Andrea J. | AGrant, award, or other acquisition | Common | 417 | $99.04 | Direct | May 7, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 4, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Jul 20, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 27, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 31, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Mar 23, 2026 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| Mar 4, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Feb 4, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 30, 2026 | 424B3 | — | Prospectus filing | Capital-related | Filing |
| Nov 24, 2025 | 8-K | 8.01 | Other event | — | Filing |
| Nov 19, 2025 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Nov 12, 2025 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Oct 20, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $3.7B | +16.5% |
| Ended Mar 31, 2026 | $3.3B | +12.9% |
| Ended Sep 30, 2025 | $3.2B | +4.2% |
| Ended Jun 30, 2025 | $3.1B | +3.6% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $12.4B | +4.8% |
| Ended Dec 31, 2024 | $11.8B | -1.7% |
| Ended Dec 31, 2023 | $12.0B | -7.2% |
| Ended Dec 31, 2022 | $12.9B | +13.6% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 5.1M | $108.88 | |||
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Aug 6, 2026 filed · 37d Schedule 13G amendment | Reported reduction | 6.6K -8.8M | 5.90% -1.38 pts | $111.82 | $121.10 | $108.88 |
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 29, 2026 filed · 29d Initial Schedule 13G | Initial Schedule 13G | 5.9M | 5.28% | $100.25 | $99.02 | $108.88 |
Compare CCK with other securities showing similar institutional activity or recent accumulation across several tracked institutions.